Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pituitary ACTH Hypersecretion 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Hypertension 1Fallopian Tube Neoplasms 1Diabetes Mellitus, Type 2 1Cushing Syndrome 1Adrenocortical Carcinoma 1Adrenal Cortex Neoplasms 1ACTH Syndrome, Ectopic 1

Interventions

relacorilant 1Staining and Labeling 1Metyrapone 1Forest Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × ACTH Syndrome, Ectopic × relacorilant × Clear all
NCT03604198 2026-04-21

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Corcept Therapeutics

Phase 2 Active not recruiting
125 enrolled
Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡